Trial Profile
Phase 2 Study With Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Doxorubicin (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 28 Aug 2018 Status changed from active,no longer recruiting to discontinued.
- 20 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 10 Dec 2008 New trial record.